-
Je něco špatně v tomto záznamu ?
Utilization of an automated pipetting system in the cell line-based screening of the activity of a DNA-damaging anti-tumour drug
T. Suchánková, P. Ovesná, P. Samadder, K. Souček
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT13573
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
ProQuest Central
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
- MeSH
- automatizace MeSH
- buněčné kultury metody MeSH
- hydroxymočovina farmakologie MeSH
- karcinogeneze účinky léků patologie MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- poškození DNA * MeSH
- protinádorové látky farmakologie MeSH
- regresní analýza MeSH
- screeningové testy protinádorových léčiv * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The principles of large screening strategies, which are developed by industrial companies, have been recently adopted by researchers in the fields of molecular biology and oncology as invaluable tools for translational medicine. The declining costs of laboratory robotic machines have allowed high-throughput screening to become more available to academic centres with limited resources. Here, we describe how a robotic conventional liquid handling system could be used on a daily basis in laboratories to obtain consistent and reproducible results. Our approach allowed us to quickly screen a panel of more than 20 tumorigenic and non-tumorigenic cell lines for their responses to hydroxyurea, which is a DNA-damaging anticancer therapeutic drug. The format of 384-well microplates was used for manual cell seeding, and the effect of hydroxyurea was screened at multiple concentrations. The fluorescence-based CyQuant assay was employed as the readout method to analyse the cellular DNA content. The effectiveness of our approach was demonstrated in the experimental results.
Institute of Biophysics Academy of Sciences of the Czech Republic v v i Brno Czech Republic
Institute of Biostatistics and Analyses Masaryk University Brno Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013239
- 003
- CZ-PrNML
- 005
- 20191025132654.0
- 007
- ta
- 008
- 170418s2014 xr d f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)25369341
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Suchánková, Tereza, $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v. v. i., Brno, Czech Republic $d 1983- $7 mub2011617906
- 245 10
- $a Utilization of an automated pipetting system in the cell line-based screening of the activity of a DNA-damaging anti-tumour drug / $c T. Suchánková, P. Ovesná, P. Samadder, K. Souček
- 520 9_
- $a The principles of large screening strategies, which are developed by industrial companies, have been recently adopted by researchers in the fields of molecular biology and oncology as invaluable tools for translational medicine. The declining costs of laboratory robotic machines have allowed high-throughput screening to become more available to academic centres with limited resources. Here, we describe how a robotic conventional liquid handling system could be used on a daily basis in laboratories to obtain consistent and reproducible results. Our approach allowed us to quickly screen a panel of more than 20 tumorigenic and non-tumorigenic cell lines for their responses to hydroxyurea, which is a DNA-damaging anticancer therapeutic drug. The format of 384-well microplates was used for manual cell seeding, and the effect of hydroxyurea was screened at multiple concentrations. The fluorescence-based CyQuant assay was employed as the readout method to analyse the cellular DNA content. The effectiveness of our approach was demonstrated in the experimental results.
- 650 _2
- $a protinádorové látky $x farmakologie $7 D000970
- 650 _2
- $a automatizace $7 D001331
- 650 _2
- $a karcinogeneze $x účinky léků $x patologie $7 D063646
- 650 _2
- $a buněčné kultury $x metody $7 D018929
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 12
- $a poškození DNA $7 D004249
- 650 12
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydroxymočovina $x farmakologie $7 D006918
- 650 _2
- $a regresní analýza $7 D012044
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ovesná, Petra, $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic $d 1982- $7 mub2013761100
- 700 1_
- $a Samadder, P. $u National Centre for Biomolecular Research, Faculty of Science and Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 _AN091251
- 700 1_
- $a Souček, Karel $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v. v. i., Brno, Czech Republic; Centre of Biomolecular and Cellular Engineering, International Clinical Research Centre, St. Anne's University Hospital Brno, Brno, Czech Republic $7 xx0140754
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 60, Suppl. 1 (2014), s. 50-55
- 856 41
- $u https://fb.cuni.cz/file/5745/fb2014a0032.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 4 $z 0
- 990 __
- $a 20170418 $b ABA008
- 991 __
- $a 20191025133130 $b ABA008
- 999 __
- $a ok $b bmc $g 1201709 $s 974017
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 60 $c Suppl. 1 $d 50-55 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- GRA __
- $a NT13573 $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20170418